Koers Getein Biotech, Inc
Aandelen
603387
CNE100002RR9
Medische apparatuur, benodigdheden & distributie
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
9,04 CNY | +0,44% | +4,75% | -17,82% |
Omzet 2021 | 1,4 mld. 193 mln. 181 mln. | Omzet 2022 | 1,82 mld. 251 mln. 235 mln. | Marktkapitalisatie | 6,34 mld. 875 mln. 818 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | 399 mln. 55,07 mln. 51,5 mln. | Nettowinst (verlies) 2022 | 499 mln. 68,87 mln. 64,41 mln. | EV/omzet 2021 | 4,4 x |
Nettoliquiditeiten 2021 | 1,09 mld. 150 mln. 140 mln. | Nettoliquiditeiten 2022 | 566 mln. 78,17 mln. 73,11 mln. | EV/omzet 2022 | 3,17 x |
K/w-verhouding 2021 |
18,2
x | K/w-verhouding 2022 |
12,8
x | Werknemers | 2.508 |
Dividendrendement 2021 |
1,7% | Dividendrendement 2022 |
2,72% | Vrij verhandelbaar | 52,62% |
1 dag | +0,44% | ||
1 week | +4,75% | ||
Lopende maand | -1,74% | ||
1 maand | -2,69% | ||
3 maanden | -6,22% | ||
6 maanden | -19,36% | ||
Lopend jaar | -17,82% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
En Ben Su
CEO | Chief Executive Officer | 58 | 08-03-02 |
Wen Ni
DFI | Director of Finance/CFO | 41 | 01-01-13 |
Gang Zhu
BRD | Director/Board Member | 38 | 01-01-12 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jing Luo
BRD | Director/Board Member | 62 | 16-09-22 |
En Ben Su
CEO | Chief Executive Officer | 58 | 08-03-02 |
Bin Yan
BRD | Director/Board Member | 42 | 01-01-10 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.07% | 12 M€ | -16,71% | - | |
0.00% | 117 M€ | +1,11% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 9,04 | +0,44% | 3 176 996 |
25-04-24 | 9 | +2,97% | 5 530 432 |
24-04-24 | 8,74 | +0,11% | 2 975 142 |
23-04-24 | 8,73 | +0,92% | 2 704 688 |
22-04-24 | 8,65 | +0,23% | 3 678 296 |
slotkoers Shanghai S.E., 26 april 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-17,82% | 633 mln. | |
+0,89% | 12,8 mld. | |
-10,29% | 7,61 mld. | |
-1,16% | 4,51 mld. | |
+5,74% | 4,49 mld. | |
-50,70% | 3,3 mld. | |
+12,21% | 2,73 mld. | |
-16,13% | 2,02 mld. | |
-11,50% | 1,73 mld. | |
-5,02% | 1,64 mld. |